Divergent effects of resveratrol, a polyphenolic phytostilbene, on free radical levels and type of cell death induced by the histone deacetylase inhibitors butyrate and trichostatin A

被引:9
作者
Galfi, P
Jakus, J
Molnar, T
Neogrady, S
Csordas, A
机构
[1] Innsbruck Med Univ, Bioctr Innsbruck, Div Med Biochem, A-6020 Innsbruck, Austria
[2] Szent Istvan Univ, Fac Vet Sci, Inst Physiol & Biochem, H-1078 Budapest, Hungary
[3] Hungarian Acad Sci, Chem Res Ctr, Inst Biomol Chem, H-1025 Budapest, Hungary
基金
匈牙利科学研究基金会;
关键词
resveratrol; N-acetylcystein; free radicals; ESR; antioxidant; pro-oxidant; apoptosis; necrosis; butyrate; trichostatin A; histone deacetylase inhibitor; stilbene; polyphenol;
D O I
10.1016/j.jsbmb.2004.12.019
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
We investigated the effects of the polyphenolic phytostilbene resveratrol on the steady-state free radical (FR) concentration and mode of cell death induced by the histone deacetylase inhibitors butyrate and trichostatin A. (i) There was no correlation between cell death induction by butyrate or trichostatin A (TSA) and FR levels. (ii) Treatment with resveratrol or N-acetyl-L-Cystein (NAC) of cells, in which the FR concentration was high, resulted in an almost complete reduction of FR levels. (iii) When, however, the cellular FR concentration was marginal, resveratrol caused a minor, and NAC a marked increase of FRs as well as of the extent of cell death. Thus, resveratrol and NAC acted as antioxidants only when the cellular FR levels were high, and acted as pro-oxidants when facing a low FR concentration. (iv) Since resveratrol and the antioxidant NAC exhibited analogous effects, it is concluded that the observed actions of resveratrol are due to polyphenolic redox reactions and not related to the stilbene moiety of the molecule. (v) The results indicate that the redox status of a given cell type plays an important role in determining whether resveratrol and other antioxidants promote cell death or protect cells from it. (c) 2005 Elsevier Ltd. All rights reserved.
引用
收藏
页码:39 / 47
页数:9
相关论文
共 35 条
[1]   Resveratrol inhibits drug-induced apoptosis in human leukemia cells by creating an intracellular milieu nonpermissive for death execution [J].
Ahmad, KA ;
Clement, MV ;
Hanif, IM ;
Pervaiz, S .
CANCER RESEARCH, 2004, 64 (04) :1452-1459
[2]   Inhibition of cancer growth by resveratrol is related to its low bioavailability [J].
Asensi, M ;
Medina, I ;
Ortega, A ;
Carretero, J ;
Baño, MC ;
Obrador, E ;
Estrela, JM .
FREE RADICAL BIOLOGY AND MEDICINE, 2002, 33 (03) :387-398
[3]  
Aziz MH, 2003, INT J ONCOL, V23, P17
[4]   Resveratrol causes arrest in the S-phase prior to Fas-independent apoptosis in CEM-C7H2 acute leukemia cells [J].
Bernhard, D ;
Tinhofer, I ;
Tonko, M ;
Hübl, H ;
Ausserlechner, MJ ;
Greil, R ;
Kofler, R ;
Csordas, A .
CELL DEATH AND DIFFERENTIATION, 2000, 7 (09) :834-842
[5]  
Bertelli A, 1998, DRUG EXP CLIN RES, V24, P133
[6]  
Bhat KPL, 2001, CANCER RES, V61, P7456
[7]   Wine and resveratrol: mechanisms of cancer prevention? [J].
Bianchini, F ;
Vainio, H .
EUROPEAN JOURNAL OF CANCER PREVENTION, 2003, 12 (05) :417-425
[8]   Resveratrol acts as a mixed agonist/antagonist for estrogen receptors α and β [J].
Bowers, JL ;
Tyulmenkov, VV ;
Jernigan, SC ;
Klinge, CM .
ENDOCRINOLOGY, 2000, 141 (10) :3657-3667
[9]   SUPEROXIDE AND HYDROGEN-PEROXIDE IN RELATION TO MAMMALIAN-CELL PROLIFERATION [J].
BURDON, RH .
FREE RADICAL BIOLOGY AND MEDICINE, 1995, 18 (04) :775-794
[10]  
Cardile V, 2003, ANTICANCER RES, V23, P4921